Herpetic Oral Manifestation In Acute Myeloid Leukemia
case report
DOI:
https://doi.org/10.5935/2525-5711.20160006Keywords:
herpes simplex, immunosuppression, leukemia, myeloid, acute, oral medicineAbstract
Viral infections in the oral cavity are frequent complications in patients with immunosuppression.The herpes simplex virus is among the most frequent causes of these infections. In immunocompromised patients the presentation may be atypical, with more extensive lesions, painful and with slower recovery.The goal of this article is to present a illustrative case of herpes oral infection in an immunosuppressed patient. Case report: Female patient, 43 years old, 32 days after the start of chemotherapy for acute myeloid leukemia, began complaining of odynophagia and painful emergence of lesions in the oral cavity. She presented multiple whitish ulcerated lesions with an erythematous halo, measuring around 0.5 cm in diameter across the mouth and the posterior wall of oropharynx. Treated with acyclovir with rapid improvement of symptoms and lesions. Cytological changes were found compatible with herpes simplex. Discussion: In most cases of infection with herpes simplex the presentations are self-limited but severe infections may occur and atypical in immunosuppressed individuals. Additional exams help in diagnosis as diagnostic cytology, ELISA and direct immunofluorescence. Acyclovir is the drug of choice for the treatment recommended dose of 1 g/day for a minimum period of 10 days. Conclusion: The oral lesions of herpes virus in immunosuppressed patients may have varied presentations and can often go unnoticed, as in mild or asymptomatic cases. However, due to the possibility of systemic spread of infection and the occurrence of severe manifestations, one should be highly suspected before the appearance of any oral lesion in the immunosupressed patients.
References
Heimdahl A. Prevention and management of oral infections in cancer
patients. Support Care Cancer. 1999;7:224-28 DOI: http://dx.doi.
org/10.1007/s005200050253
Childers NK, Stinett EA,Wheeler P et al. Oral complications in chil-
dren with cancer. Oral Surg Oral Med Oral Pathol. 1993;75:41-7.
DOI: http://dx.doi.org/10.1016/0030-4220(93)90404-R
Dreizen S, Bodey GP, Valdivieso M. Chemotherapy-associated oral
infections in adults with solid tumors. Oral Surg Oral Med Oral
Pathol. 1983;55:113-120 DOI: http://dx.doi.org/10.1016/0030-
(83)90164-0
Maltezou HC, Kafetzis DA, Abisaid D, et al.Viral infections in children
undergoing hematopoietic stem cell transplant. Pediatr Infect Dis J.
; 19:307-12. DOI: http://dx.doi.org/10.1097/00006454-
-00009
Wright S W, Johnson RA. Human Immunodeficiency virus in wo-
men. Clin Dermatol. 1997;15(1):93-111. DOI: http://dx.doi.
org/10.1016/S0738-081X(96)00113-7
Schubert MM, Peterson DE, Flournoy N et al. Oral and pharyngeal
herpes simplex virus infection after allogeneic bone marrow trans-
plantation: analysis of factors associated with infection. Oral Surg Oral
Med Oral Pathol. 1990;70(3):286-93. PMID: 2170891 DOI: http://
dx.doi.org/10.1016/0030-4220(90)90142-F
Costa DD, Duplat CBS, Mariano MMC et al. Orofacial manifestations
of the Levy-Hollister syndrome. J. Oral Diag. 2012;1(1):26-30
Lupi O, Pereira Jr. AC. Herpesvírus humanos, considerações estruturais
e imunopatogênicas. An Acad Nac Med. 1994;27-9
Lupi O, Pereira Jr. AC. Herpes simples. In: Lupi O, Silva AG, Pereira Jr.
AC. Herpes: clínica, diagnóstico e tratamento. Rio de Janeiro: Medsi;
:p.43-70
Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet.
;357:1513-1518 DOI: http://dx.doi.org/10.1016/S0140-
(00)04638-9
Yahav D, Gafter-Gvili A, Muchtar E et al. Antiviral prophylaxis in
haematological patients: systematic review and meta-analysis. Eur J
Cancer. 2009; 45(18):3131-48. DOI: http://dx.doi.org/10.1016/j.
ejca.2009.08.010
Meyers JD, Flournoy N, Thomas ED. Infection with herpes sim-
plex virus and cell-mediated immunity after marrow transplant. J
Infect Dis 1980;142:338-46. DOI: http://dx.doi.org/10.1093/
infdis/142.3.338
Odds FC.Candida and Candidosis. BailliereTindall, Philadelphia; 1998.
Calderone RA. Candida and Candidiasis. ASM Press,Washington DC;
DOI: http://dx.doi.org/10.1086/341420
Calderone RA, FonziWA.Virulence factors of Candida albicans.Trends
Microbiol. 2001;9:327-35. DOI: http://dx.doi.org/10.1016/S0966-
-842X(01)02094-7
Naglik J, Albrecht A, Bader O et al. Candida albicans proteinases and
host/pathogen interactions. Cell Microbiol 2004;6:915-926. DOI:
http://dx.doi.org/10.1111/j.1462-5822.2004.00439.x
Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted
aspartyl proteinases in virulence and pathogenesis. Microbiol Mol
Biol Rev. 2003;67:400-28. DOI: http://dx.doi.org/10.1128/
MMBR.67.3.400-428.2003
Soll DR. Phenotypic switching. In: Calderone RA, editor. Candida
and Candidiasis. ASM press, Washington, D.C; 2002.p.123-42.
Beard JS, Frishberg DP, Sau P et al. Ominous Tzanck smear in primary
herpes simplex virus infection. Arch Dermatol. 1993;129:966-8. DOI:
http://dx.doi.org/10.1001/archderm.1993.01680290038006
Nahass GT, Goldstein BA, ZhuWY et al. Comparision of Tzanck smear,
viral culture, and DNA diagnostic methods in detection of HSV and
varicella zoster infection. JAMA 1992;268:2541-4.
Strauss, S.; Smith, H.; Brickman, C. Acyclovir for chronic muco-
cutaneous herpes simplex virus infection in immunosuppressed
patients. Ann Intern Med. 1982;96:270-7. DOI: http://dx.doi.
org/10.7326/0003-4819-96-3-270
